ACTIVE_NOT_RECRUITING

Multi-Center Project: Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will test an automated, electronic health record (EHR-)embedded alert to improve prescribing of guideline-directed medical therapy for patients with heart failure and reduced ejection fraction (HFrEF). The investigators have previously tested and implemented this alert at NYU Langone Health (NYULH), and will now test and implement this alert across three other health systems.

Official Title

Multi-Center Project: BETTER CARE - HF (Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure)

Quick Facts

Study Start:2025-04-04
Study Completion:2026-03-29
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT06457152

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patient with an encounter visit at participating cardiology practice during the study period
  2. * Patient with EF of less than or equal to 40% on most recent echocardiogram at the time of visit
  3. * Patient ages 18-90
  1. * Pregnancy
  2. * Ventricular assist device
  3. * Hospice
  4. * Cardiac amyloid
  5. * Medication-specific exclusion for MRA: most recent systolic blood pressure less than 105 mm Hg, most recent potassium \< 5.1, any potassium \> 5.5, most recent glomerular filtration rate \< 30 (using MDRD equation), or a documented MRA allergy.

Contacts and Locations

Principal Investigator

Amrita Mukhopadhyay
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

University of Massachusetts
Boston, Massachusetts, 01003
United States
NYU Langone Health
New York, New York, 10016
United States
OhioHealth
Columbus, Ohio, 43228
United States
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Amrita Mukhopadhyay, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-04
Study Completion Date2026-03-29

Study Record Updates

Study Start Date2025-04-04
Study Completion Date2026-03-29

Terms related to this study

Additional Relevant MeSH Terms

  • Heart Failure